AB
ENFN

Amalgamated Bank’s Enfusion, Inc. ENFN Stock Holding History

Amalgamated Bank’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,714
Closed -$19K – 3186
2025
Q1 		$19K Buy
1,714
+369
+27% +$4.08K ﹤0.01% 2081
2024
Q4 		$14K Hold
1,345
– – ﹤0.01% 2297
2024
Q3 		$13K Hold
1,345
– – ﹤0.01% 2345
2024
Q2 		$11K Hold
1,345
– – ﹤0.01% 2415
2024
Q1 		$12K Sell
1,345
-3,619
-73% -$31.8K ﹤0.01% 2369
2023
Q4 		$48K Sell
4,964
-266
-5% -$2.48K ﹤0.01% 2277
2023
Q3 		$47K Buy
5,230
+1,317
+34% +$12.5K ﹤0.01% 2284
2023
Q2 		$44K Buy
3,913
+223
+6% +$1.98K ﹤0.01% 2381
2023
Q1 		$39K Sell
3,690
-472
-11% -$5.2K ﹤0.01% 2410
2022
Q4 		$40K Hold
4,162
– – ﹤0.01% 2526
2022
Q3 		$51K Buy
4,162
+126
+3% +$1.54K ﹤0.01% 2456
2022
Q2 		$41K Buy
4,036
+704
+21% +$7.78K ﹤0.01% 2581
2022
Q1 		$42K Buy
+3,332
New +$50.9K ﹤0.01% 2562

Other funds holding ENFN

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Amalgamated Bank's ENFN Position: Q2 2025 in Review

Amalgamated Bank sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 1,714 shares — an estimated $19K sold.

Amalgamated Bank first reported a position in ENFN in Q1 2022 and held it in 13 quarters. The position peaked at $51K in Q3 2022. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

  • Amalgamated Bank reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
  • Amalgamated Bank sold 1,714 Enfusion, Inc. shares in Q2 2025, an estimated $19K.
  • Amalgamated Bank first reported a position in Enfusion, Inc. in Q1 2022 and held it in 13 quarters.
  • Amalgamated Bank's Enfusion, Inc. position peaked at $51K in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Amalgamated Bank's 13F filing for Q2 2025, filed 4 Aug 2025.